Cosmos & Physics
New Quintuple Agonist Shows Promise for Obesity and Diabetes in Mice
In obese mice, a single experimental drug molecule, a GLP-1R GIPR PPAR quintuple agonist, led to greater weight loss and better blood sugar control than semaglutide (Ozempic) and a standard GLP-1/GIP
Dr. Evelyn Reed·May 18, 2026
